Cargando…

Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside

Mild hypercortisolism is defined as biochemical evidence of abnormal cortisol secretion without the classical detectable manifestations of overt Cushing’s syndrome and, above all, lacking catabolic characteristics such as central muscle weakness, adipose tissue redistribution, skin fragility and unu...

Descripción completa

Detalles Bibliográficos
Autores principales: Favero, Vittoria, Cremaschi, Arianna, Parazzoli, Chiara, Falchetti, Alberto, Gaudio, Agostino, Gennari, Luigi, Scillitani, Alfredo, Vescini, Fabio, Morelli, Valentina, Aresta, Carmen, Chiodini, Iacopo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775422/
https://www.ncbi.nlm.nih.gov/pubmed/35054858
http://dx.doi.org/10.3390/ijms23020673
_version_ 1784636581378785280
author Favero, Vittoria
Cremaschi, Arianna
Parazzoli, Chiara
Falchetti, Alberto
Gaudio, Agostino
Gennari, Luigi
Scillitani, Alfredo
Vescini, Fabio
Morelli, Valentina
Aresta, Carmen
Chiodini, Iacopo
author_facet Favero, Vittoria
Cremaschi, Arianna
Parazzoli, Chiara
Falchetti, Alberto
Gaudio, Agostino
Gennari, Luigi
Scillitani, Alfredo
Vescini, Fabio
Morelli, Valentina
Aresta, Carmen
Chiodini, Iacopo
author_sort Favero, Vittoria
collection PubMed
description Mild hypercortisolism is defined as biochemical evidence of abnormal cortisol secretion without the classical detectable manifestations of overt Cushing’s syndrome and, above all, lacking catabolic characteristics such as central muscle weakness, adipose tissue redistribution, skin fragility and unusual infections. Mild hypercortisolism is frequently discovered in patients with adrenal incidentalomas, with a prevalence ranging between 5 and 50%. This high variability is mainly due to the different criteria used for defining this condition. This subtle cortisol excess has also been described in patients with incidentally discovered pituitary tumors with an estimated prevalence of 5%. To date, the mechanisms responsible for the pathogenesis of mild hypercortisolism of pituitary origin are still not well clarified. At variance, recent advances have been made in understanding the genetic background of bilateral and unilateral adrenal adenomas causing mild hypercortisolism. Some recent data suggest that the clinical effects of glucocorticoid (GC) exposure on peripheral tissues are determined not only by the amount of the adrenal GC production but also by the peripheral GC metabolism and by the GC sensitivity. Indeed, in subjects with normal cortisol secretion, the combined estimate of cortisol secretion, cortisone-to-cortisol peripheral activation by the 11 beta-hydroxysteroid dehydrogenase enzyme and GC receptor sensitizing variants have been suggested to be associated with the presence of hypertension, diabetes and bone fragility, which are three well-known consequences of hypercortisolism. This review focuses on the pathophysiologic mechanism underlying both the different sources of mild hypercortisolism and their clinical consequences (bone fragility, arterial hypertension, subclinical atherosclerosis, cardiovascular remodeling, dyslipidemia, glucose metabolism impairment, visceral adiposity, infections, muscle damage, mood disorders and coagulation).
format Online
Article
Text
id pubmed-8775422
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87754222022-01-21 Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside Favero, Vittoria Cremaschi, Arianna Parazzoli, Chiara Falchetti, Alberto Gaudio, Agostino Gennari, Luigi Scillitani, Alfredo Vescini, Fabio Morelli, Valentina Aresta, Carmen Chiodini, Iacopo Int J Mol Sci Review Mild hypercortisolism is defined as biochemical evidence of abnormal cortisol secretion without the classical detectable manifestations of overt Cushing’s syndrome and, above all, lacking catabolic characteristics such as central muscle weakness, adipose tissue redistribution, skin fragility and unusual infections. Mild hypercortisolism is frequently discovered in patients with adrenal incidentalomas, with a prevalence ranging between 5 and 50%. This high variability is mainly due to the different criteria used for defining this condition. This subtle cortisol excess has also been described in patients with incidentally discovered pituitary tumors with an estimated prevalence of 5%. To date, the mechanisms responsible for the pathogenesis of mild hypercortisolism of pituitary origin are still not well clarified. At variance, recent advances have been made in understanding the genetic background of bilateral and unilateral adrenal adenomas causing mild hypercortisolism. Some recent data suggest that the clinical effects of glucocorticoid (GC) exposure on peripheral tissues are determined not only by the amount of the adrenal GC production but also by the peripheral GC metabolism and by the GC sensitivity. Indeed, in subjects with normal cortisol secretion, the combined estimate of cortisol secretion, cortisone-to-cortisol peripheral activation by the 11 beta-hydroxysteroid dehydrogenase enzyme and GC receptor sensitizing variants have been suggested to be associated with the presence of hypertension, diabetes and bone fragility, which are three well-known consequences of hypercortisolism. This review focuses on the pathophysiologic mechanism underlying both the different sources of mild hypercortisolism and their clinical consequences (bone fragility, arterial hypertension, subclinical atherosclerosis, cardiovascular remodeling, dyslipidemia, glucose metabolism impairment, visceral adiposity, infections, muscle damage, mood disorders and coagulation). MDPI 2022-01-08 /pmc/articles/PMC8775422/ /pubmed/35054858 http://dx.doi.org/10.3390/ijms23020673 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Favero, Vittoria
Cremaschi, Arianna
Parazzoli, Chiara
Falchetti, Alberto
Gaudio, Agostino
Gennari, Luigi
Scillitani, Alfredo
Vescini, Fabio
Morelli, Valentina
Aresta, Carmen
Chiodini, Iacopo
Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside
title Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside
title_full Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside
title_fullStr Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside
title_full_unstemmed Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside
title_short Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside
title_sort pathophysiology of mild hypercortisolism: from the bench to the bedside
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775422/
https://www.ncbi.nlm.nih.gov/pubmed/35054858
http://dx.doi.org/10.3390/ijms23020673
work_keys_str_mv AT faverovittoria pathophysiologyofmildhypercortisolismfromthebenchtothebedside
AT cremaschiarianna pathophysiologyofmildhypercortisolismfromthebenchtothebedside
AT parazzolichiara pathophysiologyofmildhypercortisolismfromthebenchtothebedside
AT falchettialberto pathophysiologyofmildhypercortisolismfromthebenchtothebedside
AT gaudioagostino pathophysiologyofmildhypercortisolismfromthebenchtothebedside
AT gennariluigi pathophysiologyofmildhypercortisolismfromthebenchtothebedside
AT scillitanialfredo pathophysiologyofmildhypercortisolismfromthebenchtothebedside
AT vescinifabio pathophysiologyofmildhypercortisolismfromthebenchtothebedside
AT morellivalentina pathophysiologyofmildhypercortisolismfromthebenchtothebedside
AT arestacarmen pathophysiologyofmildhypercortisolismfromthebenchtothebedside
AT chiodiniiacopo pathophysiologyofmildhypercortisolismfromthebenchtothebedside